Health on MSN3d
What To Know About Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...
Nonalcoholic Steatohepatitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...
Tahoe Daily Tribune6d
Non-alcoholic fatty liver disease
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Liver diseases
The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...
European Medical Journal1d
Managing MASLD in Patients with Type 2 Diabetes
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
Hepion Pharmaceuticals Announces Reverse Stock Split
Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion ...
Medical Xpress on MSN9d
Researchers identify a gene to guide novel therapeutics of nonalcoholic fatty liver diseases
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
Aligos Therapeutics (ALGS) to Release Quarterly Earnings on Monday
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) is expected to be releasing its earnings data before the market opens on ...